India Pharma Outlook Team | Thursday, 12 February 2026
USV Pharma is leading talks to acquire an 85% stake in Wellbeing Nutrition at a Rs 1,600 crore valuation, a deal that could shake up India’s consumer health space.
Its direct-to-consumer nutrition brand, which offers supplements such as whey protein and Omega-3 fish oil, has received a great deal of interest. Providing the discussions are successful, it will be one of the largest moves by a pharmaceutical competitor into the expanding wellness market.
Wellbeing Nutrition has brands to support and the support will be fruitful. Early investors of Hindustan Unilever and Fireside Ventures are to exit with over four times their initial returns on investing when the company was estimated at about 350 crore three years ago.
Also Read: How a Culture of Thanks Fuels Retention in Hospitals
Founder Avnish Chhabria, who currently owns 51% of the company, would fetch around 800 crore on the deal. He will sell out a 35 percent of the stock at the moment though with an option to dilute some more in future yet remain in control of the business. The founder of Wellbeing owns half of the company unlike many other D2C companies and founders who had to dilute their own stocks to raise millions and he has already raised ten million dollars to date.
The income of Wellbeing Nutrition has increased almost threefold within a span of two years, yet it is making losses because of high expenditure on brand building and diversifying its products.
In the case of USV Pharma, the acquisition will provide the rapid entry to consumer health and nutrition market with a value of more than Rs 21,000 crore, which will expand its presence beyond prescription vitamins and calcium products. Formal announcement may be as early as this week as per those who are privy to the negotiations.
